Net profit of Welcure Drugs & Pharmaceuticals reported to Rs 2.54 crore in the quarter ended March 2025 as against net loss of Rs 0.02 crore during the previous quarter ended March 2024. Sales reported to Rs 21.21 crore in the quarter ended March 2025. There were no Sales reported during the previous quarter ended March 2024.For the full year,net profit reported to Rs 2.17 crore in the year ended March 2025 as against net loss of Rs 0.17 crore during the previous year ended March 2024. Sales reported to Rs 24.55 crore in the year ended March 2025. There were no Sales reported during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales21.210 0 24.550 0 OPM %3.020 -3.580 - PBDT2.550 0 2.79-0.13 LP PBT2.54-0.02 LP 2.78-0.17 LP NP2.54-0.02 LP 2.17-0.17 LP Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live News

Net profit of Welcure Drugs & Pharmaceuticals reported to Rs 0.41 crore in the quarter ended December 2024 as against net loss of Rs 0.03 crore during the previous quarter ended December 2023. Sales reported to Rs 8.84 crore in the quarter ended December 2024. There were no Sales reported during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales8.840 0 OPM %10.290 - PBDT0.91-0.02 LP PBT0.91-0.03 LP NP0.41-0.03 LP Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live News